reason report
survey show dd growth despit lengthi turnaround
bottom line believ address market impella
remain unchang highli under-penetrated also believ
enter new phase adopt curv next
wave adopt requir focu heavi lift better
understand near-term sustain growth profil
might embark medacorp survey assess recent
project volum center show slight major
still sizabl number center
expect see flat-to-declin volum next
year ultim base medacorp survey recent
medacorp physician convers believ high-single-digit
 sale growth worst-cas scenario near-term given
size even limit balloon pump still
done annual would suggest doubl impella
volum strength data recent initi
implement andmost importantlyth strong double-digit
growth trajectori still project major albeit slight major
center survey along eas comp head
seem better-than-expect
roll-out japan potenti growth acceler germani
european countri high-risk pci volum pick post recent
burzotta public journal intervent cardiolog
impella roll-out contribut sustain
sale overal growthat worstov next month
modestli adjust lower sale estim reflect
longer turnaround time believ like even
valuat perspect believ repres attract
risk/reward recent adopt issu well-docu investor
expect low valuat metric discount like
ew op despit nearli faster sale growth profil
modest premium mid-to-larg cap growth-i stock
valuat gotten increasingli attract acknowledg
share like rel rang bound next quarter two
reiter op pt price targetdown
previouslyappli ev/sal multipl
sale estim assum current sale multipl
hold steadi said believ near term upsid share like
limit beat rais difficult come light
potenti slower ramp adopt next wave adopt requir
focu effort part compani drive adopt
detail valuat survey analysi insid
medic suppli devic
ev/sal multipl
net debt total capit
year price history/av daili volume mil
compani inform svb leerink llc research
revenu dilut gaap ep
pleas refer page analyst certif import disclosur price chart disclosur specif
cover compani statement valuat risk avail
rate share market perform price target us
much execut stori compani continu drive adopt impella famili
percutan ventricular assist devic pvad enter next phase adopt
curv admittedli like multi-quart turnaround requir heavi lift
compani still believ double-digit growth sustain even period
transit compani like retain monopoli us heart recoveri market
opportun forese futur time-frame project sale
compound-annual-growth-rate drive adopt current high-risk pci cardiogen shock indic
highli under-penetrated market opportun
penetr base abmd market assess address patient
 includ cardiogen shock patient high-risk pci patient
right heart failur patientsal believ remain intact
geograph expans germani japan manag estim
penetr address patient germani still earli
commerci roll-out address patient market opportun japan
clear strateg plan break barrier adopt motto train data
 time compani continu train physician build clinic data
still balloon pump use cardiogen shock patient today
compar estim impella implant given
balloon pump deem class devic countri like germani
japanmean actual caus harm usedit seem clear us
technolog eventu becom obsolet impella viabl replac
believ barrier adopt gradual broken awar
spread still-build clinic dataset train continu ramp
believ drive solid double-digit sale growth exist cardiogen shock
high-risk pci indic view potenti indic expans stemi st-elev
myocardi infarct could ultim doubl exist total address market
 todaya call option compani recent receiv fda approv
initi stemi triala prospect multi-cent two-arm trial plan enrol
patient undergo treatment stemi heart attack enrol begin octob
expect finish date time frame
beyond double-digit sale growth monopoli pvad space also offer one
compel margin profil coverag univers gross margin
oper margin leverag ultim push oper margin
believ repres uniqu asset smid-cap med-tech
impella survey support view multifactori issu
turnaround like take time still buy
valuat unchang tam sustain dd growth
effort better understand near-term sustain growth profil might
embark medacorp survey assess recent project volum center
tough draw hard fast conclus survey key takeaway
major center still expect see double-digit volum growthwhil
center survey seen double-digit growth last quarter expect volum
grow double-digit expect see volum growth double-digit
expect see volum grow double-digit center project volum
growth next year averag growth rate
suggest us pocket declin volum
custom accord manag recent commentaryther still
meaning growth potenti major center
still good number expect flat-to-declin volum
next year center point recent declin driven impella rp
letter also ancillari reason includ cost lack data support vascular access
mention directli ask question
interestingli survey respond note intervent
cardiologist center implant impella point compani highlight
signific underpenetr even exist center potenti go deeper center
bring new physician on-board recent note volum done
implant physician
mean fundament fundament perspect
believ survey reflect recent well-telegraph well-docu issu
current facingbeyond impella rp fda letter fact enter new
phase adopt curv barrier around vascular access clinic data whether
unfound compani need break still seem clear
major center current user
continu double-digit growth potenti
 meaning room increment growth new user within center
cardiologist actual implant impella today
take sale estim slightli lowerbi
yearto reflect think longer turnaround essenti assum
add even fewer new center compani like focu heavili near-
term exist implant center base recent medacorp physician convers
tct transcathet cardiovascular therapi meet link sens
critic champion implant physician fulli buy technologyat
center order go deeper center drive belief like focu
first
also base recent medacorp physician convers reiter view
ultim unchang rather might take littl bit longer
heavi lift fulli unlock valu patient
ultim base medacorp survey base recent medacorp physician
convers believ high-single-digit sale growth worst-cas scenario
near-term given size even limit balloon pump still done
 annual would suggest doubl impella volum strength data
recent initi implement andmost importantlyth double-digit growth
trajectori still project major albeit slight major center survey along
eas comp head seem better-than-
expect roll-out japan potenti growth acceler germani european
countri high-risk pci volum pick post recent burzotta public journal
intervent cardiolog impella roll-out contribut
sustain overal sale growthat worstov next month
mean valuat valuat perspect mid-cap
med-tech similar growth profil market cap includ op
op op op trade sale small-cap med-tech
op trade sale us floor valuat perspect
sale coupl view worst-cas scenario
 sale growth near-term like high-single-digit arriv downsid
share rang upsid potentialassum sustain multipl current
sale sale growth translat
figur valuat sensit sale growth project
approach valuat anoth angl group similarli growth-i
med-tech stock rang mid-cap larg abmd valuat premium across sever
metric fall well short premium growth profil
look sale use consensu estim trade
premium group notabl ew op despit higher sale growth rate
ew group includ single-digit sale growth compani like op
look ebitda use consensu estim trade line
groupand notabl ew op despit higher sale growth rate ew
group
price ofev ofev salesev salesev growth rate price ofev ofev ebitdaev ebitdaev growth rate sale growth rate inc
lastli look price-to-earnings ep estim use consensu estim
trade premium groupand notabl ew op despit higher
sale growth rate ew group
acknowledg factor consid assess appropri valuat
estim upsid potentialfor examplewhich like limit near-term still
think potenti line like ew multibillion dollar rang near-to-
medium term monopoli feel like near floor valuat perspect
sale anyth sale seem unjustifi base
compar compani trade
volum increas vs flat-to-declin growth
survey poll intervent cardiologist patient total
treat center averag repres impella implant volum
 base estim though small sampl size tough discern
repres project broader market believ survey
provid direct insight current potenti futur market trend
survey defin center size base intervent cardiologist affili
particip primari center intervent cardiologist center
impella implant averag quarter cardiologist implant impella among
center seem support abmd commentaryand commentari weve heard
medacorp physician pastthat still number cardiologist exist center
implant impella also stratifi center base project impella
volum center includ survey particip implant colleagu
surprisingli positivealbeit perfectcorrel intervent
price ofev adjust ep ep growth rate ep adjust inc
cardiologist total impella volum center pleas refer appendix section
addit detail practic dynam
figur practic dynam survey particip stratifi implant volum
center expect growth vs declin suggest growth still overal
physician survey encouragingli project volum see flat modest increas
 flat year increas year vs project
decreas still survey expect volum stay flat compar
abmd commentari earn call theyr see flat-to-declin volum
center put physician project four differ
bucket decreas complet flat flat modest increas increas physician
expect impella volum increas physician
survey expect implant volum declin vote remain complet flat vote
four physician flat modest increas bucket project one year
posit growth one year flat
conclus clearli posit take-away datapoint given fairli
meaning number center project declin volum think encourag
major expect increas us indic major center see
continu growth still total center expect volum flat-to-declin
suggest higher proport center expect see thisat least surveyv
center cite alreadi see earn call could point
center see volum declin go forward current
figur direct volum chang
larg center intervent cardiologist affili center mid-siz center
less intervent cardiologist affili center small center less intervent
cardiologist affili center
high-volum center volum greater equal mid-volum center volum greater
equal less low-volum center volum less
physician project deceler implant volum growth still dd near-
across center survey physician project impella volum growth y/i
deceler y/i y/i larger/higher-volum
center disproportion drive growth also contribut deceler
data stratifi center size larg center estim highest volum growth rate
follow mid-siz center echo view major
overal volum done larger center howev larg center also project
meaning growth deceler larg center project growth
mid-siz center project volum growth
respect data stratifi implant volum conclus hold
indic higher growth higher volum center meaning growth
deceler notabl data point small centers/low-volum
center show less consist growth trend think possibl reflect bia
small sampl size small base year volum
figur project annual growth rate implant volum y/i
larg center intervent cardiologist affili center mid-siz center
less intervent cardiologist affili center small center less intervent
cardiologist affili center
high-volum center volum greater equal mid-volum center volum greater
equal less low-volum center volum less
near term growth outlook abmd seem solid despit
meaning deceler physician project annual basi ask
physician estim impella implant volum center
physician expect solid near-term growth y/i y/i
y/i y/i across center project growth
small/low-volum center volatilelik due small sampl size base year implant
volumeth growth rate larger higher volum center expect remain solid
figur project growth rate implant volum y/i
larg center intervent cardiologist affili center mid-siz center
less intervent cardiologist affili center small center less intervent
cardiologist affili center
high-volum center volum greater equal mid-volum center volum greater
equal less low-volum center volum less
sequenti growth perspect impella survey suggest implant volum
growth abmd across center survey
figur estim sequenti growth implant volum q/q
larg center intervent cardiologist affili center mid-siz center
less intervent cardiologist affili center small center less intervent
cardiologist affili center
high-volum center volum greater equal mid-volum center volum greater
equal less low-volum center volum less
notabl survey overestim sequenti volum growth past quarter
admittedli make difficult focu anyth direct natur
survey vs absolut growth number
figur sequenti growth implant volum vs actual
medacorp survey impella june compani report svb leerink estim
conclus difficult deduc precis growth rate data given variabl
center size gap actual vs predic last quarter think
key takeaway data volum still grow across size center
impli us wheel fallen bu still volum
growth exist mid-to-larg impella center project deceler next
year seem support view growth exist user start reach
steadi statei basic grow line high-risk pci/cardiogen shock
pci volum abmd recently-announc initi meant target next wave
adopt low-volum user dont use devic
impella rp fda letter contribut volum declin sole reason
physician survey saw declin impella volum cite
impella rp reason well three six physician saw declin
attribut decreas fda letter impella rp one physician point maquet
cardiohelp reason one call cost one mention lack support data one
said sure reason pleas note one physician select two reason relat
impella rp fda letter physician survey awar
interest among physician awar physician saw volum declin
associ letter physician saw declin due reason physician
see volum declin
conclus us support view impella rp fda letter primari factor
drive recent declin reason point compani also
acknowledg survey respond report declin volum
match customerswhat ceo minogu character pocketswith flat-to-
figur number survey respond report declin volum
larg center intervent cardiologist affili center mid-siz center
less intervent cardiologist affili center small center less intervent
cardiologist affili center
figur physician awar impact fda letter impella rp
larg center intervent cardiologist affili center mid-siz center
less intervent cardiologist affili center small center less intervent
cardiologist affili center
high-volum center volum greater equal mid-volum center volum greater
equal less low-volum center volum less
cardiologist implant cardiologist implant implanterlarg dynamicshigh-volum centersmid-volum centerslow-volum centerssubtotallarg inc
price targetdown previous appli ev/sal multipl
sale estim assum current sale multipl hold
steadi believ upsid share near-term limit beat rais
difficult come light potenti slower ramp adopt next wave
adopt requir focu effort part compani drive adopt
risk rate valuat includ failur drive increas util rate
and/or continu add new account steadi rate failur execut pipelin
launch new geographi potenti reimburs declin potenti competit
pvad product secur approv gain meaning market share potenti product
dollar million except per share data
total good sold
research develop expens
cog sale
sg sale
 sale
oper expens sale
compani report svb leerink estim
